Medical News

RSS

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced that it has signed a three-year single source provider contract with Novation, the industry's leading supply contracting company, for MAQUET's market-leading VASOVIEW Endoscopic Vessel Harvesting (EVH) Systems.

16 Dec 2009

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

During the 5th International Congress of Corneal Cross Linking for Keratoconus in Leipzig, Germany on December 5th, Avedro presented encouraging early clinical results for treating keratoconus, a progressive disease of the cornea of the eye. The procedure, known as Keraflex® KXL, is non-incisional and reshapes the cornea without removing any tissue.

16 Dec 2009

Cost-effective alternative to original Medicare or Medicare supplement plan for Syracuse-area residents

At a time when many people with Medicare in Syracuse are increasingly concerned about finding affordable health insurance, they now have a new Medicare Advantage option for 2010.

16 Dec 2009

Biostar Pharmaceuticals to acquire a Xi'an-based medical equipment and nutrients manufacturer for $1.1M

Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced it has signed a letter of intent ("LOI') with a Xi'an-based medical equipment and nutrients manufacturer ("Acquiree") to acquire 100% of the Acquiree for $1.1 million in cash.

16 Dec 2009

Naurex' GLYX-13 demonstrates antidepressant-like and anxiolytic-like activity without CNS-related side effects

Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.

16 Dec 2009

Reprints Desk signs distribution deals with seven STM journal publishers

Derycz Scientific, Inc., a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, today announced that wholly-owned subsidiary Reprints Desk, Inc. has signed distribution deals with seven additional scientific, technical and medical (STM) journal publishers, expanding the pay-per-view content available to Reprints Desk customers and enhancing the speed of delivery.

16 Dec 2009

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I clinical trial of its lead compound GLYX-13 and has successfully dosed the first subjects in the study.

16 Dec 2009

Walgreens offers H1N1 vaccine in 27 states

Walgreens, the nation’s largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.

16 Dec 2009

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

State government leaders, Medicaid agencies, hospital and physician associations, and other entities are formulating strategies for tapping federal stimulus money to create interoperable health information exchanges (HIEs).

16 Dec 2009

MDPathways and RNPathways launched to tackle healthcare recruitment and staffing issues

Imagine what it would be like if every physician and nurse took today off…virtual chaos. More than any other industry in the world, people are the most vital resource in healthcare. Pathways, LLC. has solved a complex healthcare recruiting and staffing problem by connecting physicians and nurses to authentic career opportunities.

16 Dec 2009

Second-quarter fiscal 2010 results announced by Sunwin International Neutraceuticals

Sunwin International Neutraceuticals, Inc. today reported results for the fiscal 2010 second quarter ended October 31, 2009.

16 Dec 2009

Positive results from Auxilium Pharmaceuticals' XIAFLEX Peyronie's disease phase IIb trial

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced top-line efficacy and safety results for the phase IIb clinical trial for XIAFLEX™ (collagenase clostridium histolyticum) in the treatment of Peyronie's disease.

16 Dec 2009

First Edition: December 16, 2009

Kaiser Health News staff writer Mary Agnes Carey explores some of the key issues within current health reform proposals related to Medicare and cost. "In an effort to rein in health costs, Senate Democrats are proposing steps that would give federal agencies more power to overhaul how Medicare pays for medical care - and thus reduce Congress' own role in running the giant program for the elderly" (Kaiser Health News).

16 Dec 2009

Patients involved in Novelos Therapeutics' pivotal Phase III trial live longer than expected

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has published an exclusive interview with the CEO of Novelos Therapeutics, Inc., Harry S. Palmin.

16 Dec 2009

Team Health Holdings prices initial public offering of 13,300,000 common stock shares

Team Health Holdings, Inc. (the "Company") announced the pricing of its initial public offering of 13,300,000 shares of common stock at $12.00 per share. All of the shares are being offered by the Company. The offering is expected to close on December 21, 2009.

16 Dec 2009

Erica Bumgarner to receive $30,000 worth of free dental care for winning in 'My Smile Bites' contest

The winner of 1-800-DENTIST's exclusive smile makeover contest called "My Smile Bites" was announced today. 34-year-old Erica Bumgarner from Atlanta, Georgia, was selected from five finalists and 490 overall contestants. Erica will receive up to $30,000 worth of free dental care.

16 Dec 2009

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

Pomegranates have already been hailed as a super-food but a team of scientists from Kingston University in South West London has found a new use for the deep red fruit. The team, led by Professor Declan Naughton, has discovered that the rind can be turned into an ointment for treating MRSA and other common hospital infections.

16 Dec 2009

3M to supply and distribute TSO3's STERIZONE 125L+ Sterilizer

TSO3 Inc. and 3M (MMM) today announced that an agreement has been reached for 3M to be the exclusive supplier and distributor of TSO3's STERIZONE(R) 125L+ Sterilizer. The partnership with TSO3, an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, will include new cycles to reach acute care facilities through 3M's global sales channel.

16 Dec 2009

New passing standard for the NCLEX-RN Examination

The National Council of State Boards of Nursing, Inc. (NCSBN®) voted on Dec. 10, 2009, to raise the passing standard for the NCLEX-RN® Examination (the National Council Licensure Examination for Registered Nurses).

16 Dec 2009

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.

16 Dec 2009

Medical News

MAQUET Cardiovascular signs single source provider contract with Novation for its VASOVIEW EVH System

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

Cost-effective alternative to original Medicare or Medicare supplement plan for Syracuse-area residents

Biostar Pharmaceuticals to acquire a Xi'an-based medical equipment and nutrients manufacturer for $1.1M

Naurex' GLYX-13 demonstrates antidepressant-like and anxiolytic-like activity without CNS-related side effects

Reprints Desk signs distribution deals with seven STM journal publishers

Naurex commences dosing in its GLYX-13 Phase I clinical trial for treatment-resistant depression

Walgreens offers H1N1 vaccine in 27 states

Thomson Reuters delivers a comprehensive HIE technology platform with analytic capabilities

MDPathways and RNPathways launched to tackle healthcare recruitment and staffing issues

Second-quarter fiscal 2010 results announced by Sunwin International Neutraceuticals

Positive results from Auxilium Pharmaceuticals' XIAFLEX Peyronie's disease phase IIb trial

First Edition: December 16, 2009

Patients involved in Novelos Therapeutics' pivotal Phase III trial live longer than expected

Team Health Holdings prices initial public offering of 13,300,000 common stock shares

Erica Bumgarner to receive $30,000 worth of free dental care for winning in 'My Smile Bites' contest

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

3M to supply and distribute TSO3's STERIZONE 125L+ Sterilizer

New passing standard for the NCLEX-RN Examination

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News